<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05056532</url>
  </required_header>
  <id_info>
    <org_study_id>PAH</org_study_id>
    <nct_id>NCT05056532</nct_id>
  </id_info>
  <brief_title>Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension</brief_title>
  <official_title>Evaluation of Primary and Accessory Respiratory Muscles and Their Influence on Exercise Capacity and Dyspnea in Pulmonary Arterial Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Giresun University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Giresun University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is that evaluation of basic and accessory respiratory muscles and their&#xD;
      relationship of six minute walk test in patient with pulmonary arterial hypertension (PAH)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 9, 2021</start_date>
  <completion_date type="Anticipated">November 22, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 22, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>pectoralis muscle strength</measure>
    <time_frame>15 minute</time_frame>
    <description>pectoralis muscle strength will be evaluated with hand held dynamometers according to muscle test technique</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serratus anterior muscle strength</measure>
    <time_frame>15 minutes</time_frame>
    <description>Serratus anterior muscle strength will be evaluated with hand held dynamometers according to muscle test technique</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sternocleidomasteoideus muscle strength</measure>
    <time_frame>15 minutes</time_frame>
    <description>sternocleidomasteoideus muscle strength will be evaluated with hand held dynamometers according to muscle test technique</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory mouth pressure</measure>
    <time_frame>15 minutes</time_frame>
    <description>Respiratory mouth pressure will be measured to determine maximally inspiratory pressure and maximally expiratory pressure according to ATS/ERS guidelines.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>6MWT</measure>
    <time_frame>30 minutes</time_frame>
    <description>Six minute walk test will be performed to evalute functionally exercise capacity according to ATS/ERS guidelines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea assessment</measure>
    <time_frame>20 minutes</time_frame>
    <description>London Chest Activity of Daily Living Scale will be used to sensation of dyspne during activity of daily living.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Pulmonary Artery Hypertension</condition>
  <arm_group>
    <arm_group_label>patients</arm_group_label>
    <description>Maximal mouth pressure will be evaluated for determine respiratory muscle strength, m. pectoralis, m. serratus anterior, m. sternocloideumasteoideus and quadriceps muscles strengths will be measured to evaluate accessory respiratory muscle strength, London chest activity of daily living scale will be done for assessment of dyspnea and six minute walk test will be used for determination of functionally capacity</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Maximal mouth pressure will be evaluated for determine respiratory muscle strength, m. pectoralis, m. serratus anterior, m. sternocloideumasteoideus and quadriceps muscles strengths will be measured to evaluate accessory respiratory muscle strength, London chest activity of daily living scale will be done for assessment of dyspnea and six minute walk test will be used for determination of functionally capacity</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>patient assessment</intervention_name>
    <description>subjective and objective measurement will be performed in patients with PAH</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patient group will be chosen among the admitted to clinic control group will consist of&#xD;
        invited volunteers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with diagnosis of pulmonary arterial hypertension&#xD;
&#xD;
          -  patients with stabil drug therapy at least three months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with obstructive and/ or restrictive lung disease comorbidity&#xD;
&#xD;
          -  severe orthopedic and/ or neurological comorbidity&#xD;
&#xD;
          -  patients with severe heart failure&#xD;
&#xD;
          -  patients with severe ischemic heart disease&#xD;
&#xD;
          -  uncooperative patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Habibe DURDU</last_name>
    <role>Principal Investigator</role>
    <affiliation>Giresun University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Habibe DURDU, MSc</last_name>
    <phone>05385924799</phone>
    <email>habibe_durdu@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istanbul university-cerrahpasa cardiology institute</name>
      <address>
        <city>Istanbul</city>
        <state>Haseki</state>
        <zip>34096</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Habibe DURDU</last_name>
      <phone>05385924799</phone>
      <email>habibe_durdu@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 20, 2021</study_first_submitted>
  <study_first_submitted_qc>September 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2021</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>respiratory muscle strength</keyword>
  <keyword>exercise capacity</keyword>
  <keyword>dyspnea</keyword>
  <keyword>accessory respiratory muscle</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Arterial Hypertension</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

